Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000301397 | SCV000342369 | pathogenic | not provided | 2016-06-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003765655 | SCV004629434 | pathogenic | Autosomal recessive limb-girdle muscular dystrophy type 2C | 2023-01-10 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with SGCG-related conditions. ClinVar contains an entry for this variant (Variation ID: 288297). For these reasons, this variant has been classified as Pathogenic. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser200Ilefs*2) in the SGCG gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SGCG are known to be pathogenic (PMID: 18285821). |
Mayo Clinic Laboratories, |
RCV000301397 | SCV005414134 | likely pathogenic | not provided | 2023-10-09 | criteria provided, single submitter | clinical testing | PM2_moderate, PVS1 |